These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3105587)

  • 1. A method to screen apolipoprotein polymorphisms in whole plasma: description of apolipoprotein A-IV variants in dyslipidemias and a reassessment of apolipoprotein A-I in Tangier disease.
    Bisgaier CL; Lee ES; Glickman RM
    Biochim Biophys Acta; 1987 Apr; 918(3):242-9. PubMed ID: 3105587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma apolipoproteins in Tangier disease, as studied with two-dimensional electrophoresis.
    Visvikis S; Dumon MF; Steinmetz J; Manabe T; Galteau MM; Clerc M; Siest G
    Clin Chem; 1987 Jan; 33(1):120-2. PubMed ID: 3100093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restriction enzyme analysis of the apolipoprotein A-I gene in fish eye disease and Tangier disease.
    Rees A; Stocks J; Schoulders C; Carlson LA; Baralle FE; Galton DJ
    Acta Med Scand; 1984; 215(3):235-7. PubMed ID: 6428166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of lipoproteins and apolipoproteins in serum of a Tangier patient by micro-scale two-dimensional electrophoresis.
    Manabe T; Visvikis S; Dumon MF; Clerc M; Siest G
    Clin Chem; 1987 Apr; 33(4):468-72. PubMed ID: 3103952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Apolipoproteinopathies].
    Assmann G
    Klin Wochenschr; 1983 Feb; 61(4):169-82. PubMed ID: 6405080
    [No Abstract]   [Full Text] [Related]  

  • 6. Tangier disease: a structural defect in apolipoprotein A-I (apoA-I Tangier).
    Kay LL; Ronan R; Schaefer EJ; Brewer HB
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2485-9. PubMed ID: 6806810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro study of the pro-apolipoprotein A-I to apolipoprotein A-I converting activity between normal and Tangier plasma.
    Edelstein C; Gordon JI; Vergani CA; Catapano AL; Pietrini V; Scanu AM
    J Clin Invest; 1984 Sep; 74(3):1098-103. PubMed ID: 6432845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins.
    Schmitz G; Assmann G; Rall SC; Mahley RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6081-5. PubMed ID: 6412234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid binding properties of the Tangier apolipoprotein A-I and its isoproteins.
    Rosseneu M; Assmann G; Taveirne MJ; Schmitz G
    J Lipid Res; 1984 Feb; 25(2):111-20. PubMed ID: 6423754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tangier disease apolipoprotein A-I compared with normal plasma A-I using monoclonal antibodies.
    Weech PK; Frohlich J; Marcel YL; N'Guyen TD; Milne RW
    Biochim Biophys Acta; 1985 Jul; 835(2):402-7. PubMed ID: 2408675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier).
    Schaefer EJ; Kay LL; Zech LA; Brewer HB
    J Clin Invest; 1982 Nov; 70(5):934-45. PubMed ID: 7130397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma apolipoprotein pattern in fish-eye disease examined by high-resolution two-dimensional electrophoresis.
    Marshall T; Williams KM; Holmquist L; Carlson LA; Vesterberg O
    Clin Chem; 1985 Dec; 31(12):2032-5. PubMed ID: 3933853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tangier disease. In vitro conversion of proapo-A-ITangier to mature APO-A-ITangier.
    Bojanovski D; Gregg RE; Brewer HB
    J Biol Chem; 1984 May; 259(10):6049-51. PubMed ID: 6725246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein A-IV polymorphism and its effect on plasma lipid and apolipoprotein concentrations.
    de Knijff P; Rosseneu M; Beisiegel U; de Keersgieter W; Frants RR; Havekes LM
    J Lipid Res; 1988 Dec; 29(12):1621-7. PubMed ID: 3244013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal apoprotein A-I isoprotein composition in patients with Tangier disease.
    Zannis VI; Lees AM; Lees RS; Breslow JL
    J Biol Chem; 1982 May; 257(9):4978-86. PubMed ID: 7068673
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic determinants of dyslipidemias.
    Breslow JL
    Monogr Atheroscler; 1985; 13():25-31. PubMed ID: 3937050
    [No Abstract]   [Full Text] [Related]  

  • 17. Familial disorders of plasma apolipoproteins.
    Sirtori CR; Franceschini G
    Klin Wochenschr; 1985 Jun; 63(11):481-9. PubMed ID: 3925218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of Tangier disease].
    Kosaka A; Hayashi H
    Rinsho Byori; 1988 Aug; 36(8):988-91. PubMed ID: 3149352
    [No Abstract]   [Full Text] [Related]  

  • 19. Japanese adult siblings with Tangier disease and statistical analysis of reported cases.
    Tarao K; Iwamura K; Fujii K; Miyake H
    Tokai J Exp Clin Med; 1984 Dec; 9(5-6):379-87. PubMed ID: 6443624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-step screening method for the polymorphism of apolipoproteins A-I, A-II, and A-IV.
    Menzel HJ; Kladetzky RG; Assmann G
    J Lipid Res; 1982 Aug; 23(6):915-22. PubMed ID: 6813412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.